Validation of the Pedigree Assessment Tool (PAT) in families with BRCA1 and BRCA2 mutations

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 240-246

  Teller, P ^a,d   Hoskins, K F ^b   Zwaagstra, A ^a   Stanislaw, C ^c   Iyengar, R ^a   Green, V L ^c   Gabram, S G A ^a  

^a EMORY UNIVERSITY   (United States)

^b OSF Saint Anthony Medical Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; ONCOGENE; OVARY CANCER; PANCREAS CANCER; PATIENT REFERRAL; PEDIGREE ANALYSIS; PEDIGREE ASSESSMENT TOOL; PREDICTION; PREDICTIVE VALIDITY; PROBABILITY; PROSTATE CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; VALIDATION STUDY;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 74649083857     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0697-9     Document Type: Article

References (35)

1. EB Claus JM Schildkraut WD Thompson NJ Risch 1996 The genetic attributable risk of breast and ovarian cancer Cancer 77 2318 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z 1:STN:280:DyaK283isV2jsg%3D%3D 8635102 (Pubitemid 26162426)
2. R Wooster BL Weber 2005 Breast and ovarian cancer N Engl J Med 348 23 2339 47 10.1056/NEJMra012284
3. D Ford DF Easton J Peto 1995 Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1457 1:CAS:528:DyaK28XktFSisw%3D%3D 8533776
4. B Newman MA Austin M Lee MC King 1988 Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families Proc Natl Acad Sci USA 85 3044 10.1073/pnas.85.9.3044 1:STN:280:DyaL1c3gtlKgtA%3D%3D 3362861
5. A Bish S Sutton C Jacobs S Levene A Ramirez S Hodgson 2002 Changes in psychological distress after cancer genetic counseling: a comparison of affected and unaffected women Br J Cancer 86 43 50 10.1038/sj.bjc.6600030 1:STN:280:DC%2BD387itFWmug%3D%3D 11857010 (Pubitemid 34146339)
6. KF Hoskins A Zwaagstra M Ranz 2006 Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening Cancer 107 8 1769 1776 10.1002/cncr.22202 16967460 (Pubitemid 44582945)
7. Breast cancer risk screening tool. www.mybreastrisk.com. Accessed 5 Feb 2009.
8. O'Neill S. Quantitative breast cancer risk assessment. In: Vogel VG, editor. Management of patients at high risk for breast cancer. Blackwell, Malden; 2000. p. 63-94.
9. The Penn II BRCA1 and BRCA2 mutation risk evaluation model official web site. https://www.afcri.upenn.edu:8022/itacc/penn2/index.asp. Accessed 5 Feb 2009.
10. SM Domchek A Eisen K Calzone, et al. 2003 Application of breast cancer risk prediction models in clinical practice J Clin Oncol 21 4 593 601 10.1200/JCO.2003.07.007 12586794 (Pubitemid 46621891)
11. TS Frank AM Deffenbaugh JE Reid, et al. 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals J Clin Oncol 20 1480 1490 10.1200/JCO.20.6.1480 1:CAS:528: DC%2BD38XivFeisbY%3D 11896095 (Pubitemid 34260526)
12. Myriad BRCA risk calculator and mutation prevalence tables. http://www.myriadtests.com/provider/brca-mutation-prevalence.htm. Accessed 5 Feb 2009.
13. Myriad BRCA risk calculator. http://www.myriadtests.com/provider/brca- risk-calculator.htm. Accessed 5 Feb 2009.
14. FE Harrell RM Califf DB Pryor, et al. 1982 Evaluating the yield of medical tests JAMA. 247 2543 2546 10.1001/jama.247.18.2543 7069920
15. The American Society of Clinical Oncology 1996 Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility J Clin Oncol 14 1730 1736
16. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Gen. 1994;55:i-iv.
17. MH Gail LA Brinton DP Byar, et al. 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879 1886 10.1093/jnci/81.24.1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D 2593165
18. ML Bondy ED Lustbader S Halabi, et al. 1994 Validation of a breast cancer risk assessment modeling women with a positive family history J Natl Cancer Inst 86 620 625 10.1093/jnci/86.8.620 1:STN:280:DyaK2c7psVGntg%3D%3D 8003106
19. JP Constantino MH Gail D Pee S Anderson CK Redmond J Benichou, et al. 1999 Validation studies for model projecting the risk of invasive breast and total breast cancer incidence J Natl Cancer Inst 91 1541 1548 10.1093/jnci/91.18.1541
20. B Rockhill D Spiegelman C Byrne DJ Hunter GA Colditz 2001 Validation of the Gail model of breast cancer risk prediction and implications for chemoprevention J Natl Cancer Inst 93 358 366 10.1093/jnci/93.5.358 1:STN:280:DC%2BD3M7pvVWruw%3D%3D 11238697
21. DM Euhus AM Leitch JF Huth GN Peters 2002 Limitations of the Gail model in the specialized breast cancer risk assessment clinic Breast J. 8 23 27 10.1046/j.1524-4741.2002.08005.x 11856157 (Pubitemid 34118480)
22. WS Rubinstein SM O'Neill JA Peters, et al. 2002 Mathematical modeling for breast cancer risk assessment. State of the art and role in medicine Oncology (Huntington) 16 8 1082 1094
23. DJ Rhodes 2002 Identifying and counseling women at increased risk for breast cancer Mayo Clin Proc 77 4 355 360 10.4065/77.4.355 11936931
24. ML Lindor RA Lindor C Apicella, et al. 2007 Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models Familial Cancer 6 473 482 10.1007/s10689-007-9150-z 1:CAS:528:DC%2BD2sXhtF2htb3I 17636425 (Pubitemid 47622262)
25. P Parmigiani S Chen E Iversen, et al. 2007 Validity of models for predicting BRCA1 and BRCA2 mutations Ann Intern Med 147 441 450 17909205
26. G Parmigiani D Berry O Aguilar 1998 Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 62 145 158 10.1086/301670 1:CAS:528:DyaK1cXhsVGrsrc%3D 9443863 (Pubitemid 28093844)
27. J Tyrer SW Duffy J Cuzick 2004 A breast cancer prediction model incorporating familial and personal risk factors Stat Med 23 1111 1130 10.1002/sim.1668 15057881 (Pubitemid 38477070)
28. AM Martin MA Blackwood D Antin-Ozerkis, et al. 2001 Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic J Clin Oncol 19 2247 2253 1:CAS:528:DC%2BD3MXjsFeqsr4%3D 11304778
29. S Panchal M Ennis S Canon LJ Bordeleau 2008 Selecting a BRCA risk assessment model for use in a familial cancer clinic BMC Med Genet. 9 116 10.1186/1471-2350-9-116 19102775
30. K Shannon ML Lubravotich DM Finkelstein B Smith SN Powell MV Seiden 2002 Model-based predictions of the BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center Cancer 94 305 313 10.1002/cncr.10223 1:CAS:528:DC%2BD38XhtV2qsr8%3D 11900216 (Pubitemid 34081358)
31. PA James R Doherty M Harris BN Mukesh A Milner M Young, et al. 2006 Optimal selection of individuals for BRCA mutation testing: a comparison of available models J Clin Oncol 24 707 715 10.1200/JCO.2005.01.9737 1:CAS:528:DC%2BD28XhvFKhtb4%3D 16446345 (Pubitemid 46630438)
32. C Capalbo E Ricevuto A Vestri, et al. 2006 Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software Eur J Hum Genet. 14 49 54 1:CAS:528:DC%2BD2MXhtlWhsr7L 16288312
33. KA Metcalfe A Finch A Poll, et al. 2008 Breast cancer risk in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation Br J Cancer 100 421 425 10.1038/sj.bjc.6604830 19088722
34. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397-406.
35. US Preventive Services Task Force 2005 Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement Ann Intern Med 143 355 361